Samsung Betting Billions on Biosimilars


May 12, 2010

The Samsung Group, one of the world's largest conglomerates, has announced its intention to invest billions of dollars to become a major player in the expanding biosimilars market. Read the Bloomberg report here.


Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments